Suppr超能文献

高脂血症治疗与肠道微生物学

Hyperlipidaemia treatment and gut microbiology.

作者信息

Zhe Liu, ChunLi Yu

机构信息

Shaanxi Provincial Nuclear Industry 215 Hospital, Xianyang, Shaanxi, China.

The First Clinical College, Zunyi Medical University, Zunyi, Guizhou, China.

出版信息

Front Microbiol. 2025 Jan 10;15:1520252. doi: 10.3389/fmicb.2024.1520252. eCollection 2024.

Abstract

Numerous studies have shown that hyperlipidaemia is closely related to the gut microbiota, and the study of microbiota in the treatment of hyperlipidaemia is undoubtedly a new target for the treatment and prevention of hyperlipidaemia. The efficacy of regulating the gut microecology and changing the structure of gut flora has been demonstrated by both western and traditional medication, biological therapy, and dietary exercise, so it is particularly important to study the relationship between gut microbiota and the treatment of hyperlipidaemia. In this review, we summarize the mechanism and relationship between the pathogenesis of hyperlipidaemia and gut microbiota, and the mechanism of hyperlipidaemia treatment by influencing the gut microbiota in various treatment modalities, which provides diversified therapeutic ideas and scientific basis for clinical treatment. It also triggers us to think about the relationship between gut microbiota and other diseases, and to explore the influence of gut microbiota is a goal that we still need to explore.

摘要

大量研究表明,高脂血症与肠道微生物群密切相关,研究微生物群在高脂血症治疗中的作用无疑是高脂血症治疗和预防的新靶点。西药、传统药物、生物疗法和饮食运动均已证实调节肠道微生态和改变肠道菌群结构的功效,因此研究肠道微生物群与高脂血症治疗之间的关系尤为重要。在这篇综述中,我们总结了高脂血症发病机制与肠道微生物群之间的机制和关系,以及各种治疗方式中通过影响肠道微生物群治疗高脂血症的机制,这为临床治疗提供了多样化的治疗思路和科学依据。它也促使我们思考肠道微生物群与其他疾病之间的关系,探索肠道微生物群的影响是我们仍需探索的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ab/11758981/dd918ca61368/fmicb-15-1520252-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验